Convergent Immune-Coagulation Programs Underlie Gastrointestinal Bleeding Risk in Portal Vein Tumor Thrombosis-Associated Hepatocellular Carcinoma and Portal Hypertension.

Hum Mutat · 2026 · PMC13162123 · PMID 42131723

Europe PMC DOI

hedged sentence

0.1500

closest p · 3.0× alpha

0.1500

boldest claim

The sentences

did not reach statistical significancep = 0.15not close (p > 0.1)

In contrast, methylation‐based survival stratification for WDR62 did not reach statistical significance (log‐rank p = 0.15) (Figure 4 I). 12.10.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.